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Abstract
Introduction: High prevalence of coeliac disease (CD) has been reported among
patients with idiopathic dilated cardiomyopathy (DCM). We evaluated the
feasibility and diagnostic accuracy of screening for CD by rapid test of anti-
transglutaminase antibodies in the cardiology outpatients’ clinic.
Material and methods: We screened the blood samples of 104 patients with
DCM, 44 of their first-degree relatives, 63 diseased controls and 101 healthy
controls for the presence of anti-transglutaminase antibodies in a drop of whole
blood using a rapid assay. This test was compared to the enzyme-linked
immunosorbent assay and the anti-endomysium antibody test. 
Results: Our rapid test was positive in three (2.9%) DCM patients, in one (2%)
relative and in one (1%) healthy control. These subjects were positive at both
control assays. Two DCM patients had iron-deficient anaemia. The healthy
relative was asymptomatic, while the healthy control experienced extreme
asthenia. The relative refused intestinal biopsy, while the others showed
histological evidence of CD. During the gluten-free diet, the patient with the
worst left ventricular ejection fraction (LVEF) underwent heart transplant, and
LVEF values improved in the other two. Anaemia and tiredness resolved in all
patients.
Conclusion: Early detection of CD in a cardiological setting allows prompt
treatment with a gluten-free diet of gluten-dependent complaints with potential
benefits for the course of DCM.
Key words: anti-transglutaminase antibodies, coeliac disease, dilative
cardiomyopathy, screening. 
Introduction
Coeliac disease (CD) is a genetically determined lifelong intolerance to
gluten from dietary cereals, with a 1% prevalence among the general
population, but a much higher one (8-20%) among at-risk populations
(first-degree relatives of coeliacs, and patients with autoimmune disorders)
[1, 2]. In CD, regular ingestion of wheat, rye and barley induces T-cell
mediated inflammation in the gut and an autoimmune response to self-
proteins, mainly tissue type-2-transglutaminase, with the production of
anti-tissue-transglutaminase antibodies (anti-tTG) [3].
In general, the classic clinical presentation is seen in subjects with
gastroenterological complaints comprising chronic diarrhoea, abdominal
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distention and pain, and sometimes malabsorption.
In the now more common atypical presentations of
the disease, gastrointestinal symptoms may be
absent or less pronounced, and extra-intestinal
features may be present such as anaemia,
osteoporosis, short stature, infertility, neurological
and cardiological problems, and associated
autoimmune diseases [2]. Because atypical
presentations are increasingly found to predo  -
minate, CD is now considered a multi-system
disorder involving all medical specialities for its
diagnosis. Early diagnosis and treatment with
a gluten-free diet (GFD) significantly reduces
mortality and prevalence of CD-associated disorders
[4]. Although definite diagnosis of CD is still based
on certain characteristic histological changes in the
jejunal intestine, serological tests for CD screening
based on detection of anti-tTG are cheaper and less
invasive, with excellent sensitivity (98%) and
specificity (95%) [5]. Given the high prevalence of
the disease, the implications of missing diagnosis
(or late recognition), and the involvement of all the
medical specialities, simple blood drop based
immunoassays have been developed and validated
for measuring anti-tTG, in order to speed up CD
diagnosis in gastroenterology settings [6] and
screen the general population [7].
Although the association between CD and heart
diseases is not clearly established [8, 9], several
reports indicate a higher CD prevalence among
patients with idiopathic dilated cardiomyopathy
(DCM) and myocarditis [10-12].
In a very recent systematic revision a higher
prevalence of CD was confirmed among patients
with cardiomyopathy; in this subgroup of patients
there was also reported an improvement of cardiac
performance after introduction of the GFD. Based
on these data the authors suggested to consider
routine CD screening in all patients suffering from
cardiomyopathy [13]. 
Here, we explore the feasibility of screening
patients with DCM and their first-degree relatives
for CD using a rapid anti-tTG assay, to be performed
by a nurse or cardiologist in the course of daily
practice in a third-level referral clinic for cardiology,
and we compared the rapid test results with 
those obtained by using a well-established
immunoenzymatic assay. 
Material and methods
Subjects 
From April 2007 to February 2008, 312 subjects
underwent screening: 104 adults with DCM 
(59 males, 45 females, median age 52 years, range
28-61), 44 first-degree relatives of these patients
(27 males, 17 females, median age 44 years, range
18-55), 63 diseased controls (43 males, 20 females,
median age 59 years, 39-72) and 101 apparently
healthy nurses and residents working in cardiology
or paediatric departments (60 males, 41 females,
median age 40 years, range 27-50). The diagnosis
of DCM was based on WHO criteria at the
Cardiovascular Department, Azienda Ospedaliera-
Universitaria of Trieste [14].
Diagnosis of DCM was based on clinical
evaluation, 12-lead ECG, echocardiography (global
and regional kinetic evaluation, ventricular size,
valvular regurgitations, haemodynamic evaluation),
Holter monitoring, exercise test and, when
indicated, coronary angiography, invasive haemo-
dynamic evaluation, and endomyocardial biopsy.
Relatives who agreed to be screened underwent
clinical evaluation, 12-lead ECG and echocar  -
diography (global and regional myocardial function,
ventricular size, valvular regurgitations, and
haemodynamic evaluation). Diseased controls were
suffering from acute coronary syndrome 
(n = 42), acute pericarditis (n = 3), valvular diseases
(n = 8), and severe ischaemic heart failure (n = 10).
Laboratory testing for coeliac disease
The rapid test for detecting IgA anti-tTG, based
on a whole blood drop, was used as previously
described [6] following the manufacturer’s
instructions (Eu-tTG Quick, Eurospital, Italy). Anti-
tTG were measured by nurses using sticks
incubated for 5 minutes in a solution containing 
10 µl of whole blood from a finger prick. Positive
results appear as varying shades of grey bands on
the sticks (Figure 1). The shades were interpreted
by two operators blind to subjects’ histories and
laboratory findings. 
At the same time, the nurses took an additional
80 µl of finger prick blood which was centrifuged:
the supernatant was tested for both IgA and IgG
anti-tTG using an ELISA assay (Eu-tTG IgG, human
IgA, Eurospital, Italy), following the manufacturer’s
instructions and for IgA anti-endomysium
antibodies (AEA), by using an immunofluorescence
assay on human umbilical cord cryosections as
previously described [15]. These assays were
performed 5-10 days after the rapid test by two
operators blind to the rapid test results. Subjects
testing negative for anti-tTG antibodies were
categorized as not having CD.
The DQA1*05/ DQB1*02 and DQA1*03/DQB1*0302
alleles, encoding the DQ2 and DQ8 heterodimers
respectively, were detected in subjects with positive
antibody tests by allele-specific PCR, using Dynal
SSP Kits (Dynal).
Small bowel biopsies
Patients positive for anti-tTG or AEA or for both
were advised to undergo small intestine biopsy,
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analysed according to Oberhuber’s classification
[16]. Patients whose results were histologically
positive were considered to have CD and were
started on GFD. The present study was approved
by the local independent Ethical Committee. 
Results
Three patients with DCM (2 males, 1 females, 3/104,
2.9%), 1/44 (2.2%) relatives, who was the daughter
of a DCM patient, and one nurse among the 101 (1%)
controls tested positive to the rapid test and to both
the anti-tTG ELISA and AEA assays. All 5 carried the
HLA DQ2 heterodimer: four agreed to undergo
intestinal biopsy which showed total villous flattening
(type 3c) in all cases. The DCM patient’s daughter
refused intestinal biopsy, but due to the extremely
high positive predictive value (100%) of co-presence
of AEA, anti-tTG and CD-related HLA, this subject was
considered as having CD. The remaining 307 subjects
(101 DCM patients; 63 sick controls; 100 healthy
controls; 43 first-degree relatives) who tested
negative to the rapid test were confirmed as negative
by both anti-tTG and AEA assays.
We did not find differences in rapid test results
compared to those obtained by ELISA assay.
At the time of CD diagnosis one DCM patient
presented with severe left ventricular dysfunction
(LVEF 20%), one DCM patient complained of
recurrent abdominal pain and iron-deficiency
anaemia (Hb 9g/dl; mean corpuscular volume 
68 fl; ferritin serum level 6 ng/ml), and one DCM
patient presented with iron-deficiency anaemia 
(Hb 11 g/dl; mean corpuscular volume 71 fl; ferritin
serum level 11 ng/ml) and severe asthenia (Table I). 
Twelve out of 101 patients affected by DCM
without CD presented with anaemia (mean value
9.5 ±2 g/dl); in these patients normal mean
corpuscular volume values (mean value 82 ±6 fl)
and serum ferritin concentration (mean value 212
±37 ng/ml) were found. The healthy relative was
asymptomatic and refused both the diagnosis of
CD and diet therapy. The healthy control
experienced severe tiredness without anaemia. 
Six months after CD diagnosis, the DCM patient
with the worst LVEF value (20%) underwent heart
transplant. Over 16 months of GFD, the LVEF values
improved in the other two DCM patients
(respectively from 38% to 47% and from 46% to
60%) and the repetitive ventricular arrhythmias
detected in one were no longer present in serial
Holter recordings. The GFD improved the anaemia
in two patients with DCM and tiredness resolved
in the third DCM patient and in the healthy control. 
Discussion
This study shows that an easy, reliable test for
detecting IgA anti-tTG antibodies makes quick
diagnosis of CD possible in a cardiological setting. This
rapid assay is just as accurate as specialized
laboratory testing, has extremely high sensitivity and
specificity values, takes fifteen minutes to obtain
a result and fits in comfortably with the nurse’s
normal working schedule. Being able to administer
such a simple test in the course of routine clinical
follow-up examinations helps in early detection of CD
and, in the case of positive results, in recognizing CD
as the causative agent of otherwise not fully
understood clinical symptoms such as tiredness and
anaemia. Furthermore, this test could be used in
a larger study population in order to establish the real
prevalence of CD in patients suffering from heart
diseases. In adulthood, complaints of a lifetime of
tiredness and anaemia are common and they
represent the most frequent symptoms found in
delayed CD diagnosis. In a recent Canadian coeliac
survey [17], 40% of adult coeliacs had consulted two
or more physicians (including a haematologist) for
untreatable anaemia prior to CD diagnosis, and the
mean delay in CD diagnosis after onset of symptoms
was 11 years. Interestingly, no patients demonstrated
DCM clinical signs among this cohort; but this might
be due to the fact that only 50% of the coeliacs
actively participated in the clinical survey. 
Figure 1. Positive and negative results for anti-
transglutaminase antibodies using the rapid
immunoassay. The first band (head-arrow) must
always appear as a technical control, the second
band (arrow) represents the positive result of the
test. No second band was detected in the first strip
incubated with a blood sample that tested negative
for anti-transglutaminase antibodies. Different
shades of grey bands identified coeliac patients in
the second and third strip 
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Also in our own patients, anaemia and chronic
fatigue had a negative effect on clinical
management, which resolved promptly thanks to
GFD, with a great improvement in their quality of
life. As previously reported [11, 12], iron-deficiency
anaemia could be a useful clinical marker for
arousing suspicion of CD in patients with
cardiomyopathy, and to use the rapid test
described above. Interestingly, those patients
without CD, but presenting anaemia, did not
show laboratory findings indicating iron-
dependent anaemia.
Diagnosis of CD in a DCM patient might also
help to treat the cardiac dysfunction, through
compliance with GFD, as reported by clinical
anecdotal experience [13]. However, further
studies are needed to confirm the hypothesis of
a positive effect of GFD on the course of DCM. In
other autoimmune diseases associated with CD,
such as autoimmune hepatitis [18], alopecia [19],
gluten-dependent ataxia [20] and dermatitis
herpetiformis [21], GFD works as a specific
therapeutic agent. 
This quick and simple test performed on patients
with DCM in a day-clinic setting is both effective
and cheap (around € 6 per test vs. € 16 for IgA-IgG
ELISA assay), and could reduce delays in CD
diagnosis and allow prompt treatment with GFD of
gluten-dependent symptoms. 
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